SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/02/18 Positiveid Corp 10-K 12/31/17 83:10M M2 Compliance/FA |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 1.08M 2: EX-21.1 Subsidiaries List HTML 25K 3: EX-31.1 Certification -- §302 - SOA'02 HTML 33K 4: EX-32.1 Certification -- §906 - SOA'02 HTML 28K 11: R1 Document and Entity Information HTML 55K 12: R2 Consolidated Balance Sheets HTML 121K 13: R3 Consolidated Balance Sheets (Parenthetical) HTML 49K 14: R4 Consolidated Statements of Operations HTML 87K 15: R5 Consolidated Statements of Operations HTML 27K (Parenthetical) 16: R6 Consolidated Statements of Changes in HTML 83K Stockholders' Deficit 17: R7 Consolidated Statements of Cash Flows HTML 136K 18: R8 Organization HTML 40K 19: R9 Summary of Significant Accounting Policies HTML 111K 20: R10 Inventories HTML 31K 21: R11 Acquisitions/Dispositions HTML 74K 22: R12 Non-Controlling Interest in Consolidated HTML 51K Subsidiary 23: R13 Intangible Assets and Goodwill HTML 54K 24: R14 Deferred Revenue HTML 28K 25: R15 Accrued Expenses HTML 32K 26: R16 Equity and Debt Financing Agreements and Fair HTML 236K Value Measurements 27: R17 Stockholders' Deficit HTML 113K 28: R18 Income Taxes HTML 50K 29: R19 Commitments and Contingencies HTML 34K 30: R20 Employment Contracts and Stock Compensation HTML 31K 31: R21 Segments HTML 64K 32: R22 Subsequent Events HTML 32K 33: R23 Summary of Significant Accounting Policies HTML 185K (Policies) 34: R24 Summary of Significant Accounting Policies HTML 44K (Tables) 35: R25 Inventories (Tables) HTML 33K 36: R26 Acquisitions/Dispositions (Tables) HTML 43K 37: R27 Non-Controlling Interest in Consolidated HTML 36K Subsidiaries (Tables) 38: R28 Intangible Assets and Goodwill (Tables) HTML 53K 39: R29 Accrued Expenses (Tables) HTML 31K 40: R30 Equity and Debt Financing Agreements and Fair HTML 81K Value Measurements (Tables) 41: R31 Stockholders' Deficit (Tables) HTML 82K 42: R32 Income Taxes (Tables) HTML 44K 43: R33 Commitments and Contingencies (Tables) HTML 28K 44: R34 Segments (Tables) HTML 62K 45: R35 Organization (Details Narrative) HTML 61K 46: R36 Summary of Significant Accounting Policies HTML 113K (Details Narrative) 47: R37 Summary of Significant Accounting Policies - HTML 49K Schedule of Equipment (Details) 48: R38 Summary of Significant Accounting Policies - HTML 39K Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) 49: R39 Inventories - Schedule of Inventories (Details) HTML 34K 50: R40 Acquisitions/Dispositions (Details Narrative) HTML 186K 51: R41 Acquisitions/Dispositions - Schedule of Asset and HTML 46K Liabilities Acquired (Details) 52: R42 Acquisitions/Dispositions - Schedule of Business HTML 36K Acquisitions by Acquisition, Contingent Consideration (Details) 53: R43 Non-Controlling Interest in Consolidated HTML 107K Subsidiary (Details Narrative) 54: R44 Non-Controlling Interest in Consolidated HTML 36K Subsidiary - Schedule of Sale on Non-controlling Interest Reconciliation (Details) 55: R45 Non-Controlling Interest in Consolidated HTML 32K Subsidiary - Schedule of Non-controlling Interest Reconciliation (Details) 56: R46 Intangible Assets (Details Narrative) HTML 40K 57: R47 Intangible Assets - Schedule of Intangible Assets HTML 41K (Details) 58: R48 Intangible Assets - Schedule of Intangible Assets HTML 34K Future Amortization Expense (Details) 59: R49 Intangible Assets - Schedule of Goodwill (Details) HTML 31K 60: R50 Deferred Revenue (Details Narrative) HTML 30K 61: R51 Accrued Expenses - Schedule of Accrued Expenses HTML 35K and Other Current Liabilities (Details) 62: R52 Equity and Debt Financing Agreements and Fair HTML 1.92M Value Measurements (Details Narrative) 63: R53 Equity and Debt Financing Agreements and Fair HTML 50K Value Measurements - Schedule of Short-term Debt (Details) 64: R54 Equity and Debt Financing Agreements and Fair HTML 38K Value Measurements - Schedule of Assumption Used Valuation Techniques (Details) 65: R55 Equity and Debt Financing Agreements and Fair HTML 36K Value Measurements - Fair Value Option Quantitative Disclosures (Details) 66: R56 Equity and Debt Financing Agreements and Fair HTML 34K Value Measurements - Schedule of Fair Value Assets and Liabilities Measured On Recurring Basis (Details) 67: R57 Stockholders' Deficit (Details Narrative) HTML 277K 68: R58 Stockholders' Deficit - Schedule of Stockholders' HTML 65K Equity Note, Warrants or Rights (Details) 69: R59 Stockholders' Deficit - Schedule of Share-based HTML 53K Compensation, Stock Options, Activity (Details) 70: R60 Stockholders' Deficit - Schedule of Share-based HTML 55K Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range (Details) 71: R61 Stockholders' Deficit - Schedule of Share-based HTML 40K Payment Award, Stock Options, Valuation Assumptions (Details) 72: R62 Income Taxes (Details Narrative) HTML 60K 73: R63 Income Taxes - Schedule of Deferred Tax Assets and HTML 47K Liabilities (Details) 74: R64 Income Taxes - Schedule of Effective Income Tax HTML 43K Rate Reconciliation (Details) 75: R65 Commitments and Contingencies (Details Narrative) HTML 43K 76: R66 Commitments and Contingencies - Schedule of Future HTML 30K Minimum Lease Payments Under Operating Leases (Details) 77: R67 Employment Contracts and Stock Compensation HTML 55K (Details Narrative) 78: R68 Segments (Details Narrative) HTML 29K 79: R69 Segments - Schedule of Segment Reporting HTML 59K Information by Segment (Details) 80: R70 Subsequent Events (Details Narrative) HTML 58K 82: XML IDEA XML File -- Filing Summary XML 157K 81: EXCEL IDEA Workbook of Financial Reports XLSX 129K 5: EX-101.INS XBRL Instance -- psid-20171231 XML 3.19M 7: EX-101.CAL XBRL Calculations -- psid-20171231_cal XML 196K 8: EX-101.DEF XBRL Definitions -- psid-20171231_def XML 1.04M 9: EX-101.LAB XBRL Labels -- psid-20171231_lab XML 1.70M 10: EX-101.PRE XBRL Presentations -- psid-20171231_pre XML 1.22M 6: EX-101.SCH XBRL Schema -- psid-20171231 XSD 302K 83: ZIP XBRL Zipped Folder -- 0001493152-18-004479-xbrl Zip 242K
Exhibit 31.1
CERTIFICATION
OF PRINCIPAL EXECUTIVE OFFICER AND
PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
I, William J. Caragol, certify that:
1. | I have reviewed this Annual Report on Form 10-K of PositiveID Corporation; | |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; | |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; | |
4. | I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act 13a- 15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared; | |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |
c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and | |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
/s/ William J. Caragol | |
William J. Caragol | |
Chairman of the Board, | |
Chief Executive Officer and Acting Chief Financial Officer | |
(Principal Executive Officer and Acting Principal Financial Officer) |
C:
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 4/2/18 | None on these Dates | ||
For Period end: | 12/31/17 | |||
List all Filings |